← Back to Clinical Trials
Recruiting Phase 1 NCT05969795

NCT05969795 Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05969795
Status Recruiting
Phase Phase 1
Sponsor ART Fertility Clinics LLC
Condition Pregnancy Related
Study Type INTERVENTIONAL
Enrollment 342 participants
Start Date 2023-09-05
Primary Completion 2026-04-30

Trial Parameters

Condition Pregnancy Related
Sponsor ART Fertility Clinics LLC
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 342
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2023-09-05
Completion 2026-04-30
Interventions
Transvaginal ultrasoundSerial serum LH, E2, P4Progesterone 100 Mg Vaginal Insert

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To evaluate whether single euploid embryo transfer in NC without routinely administered LPS is non-inferior to NC with routinely administered LPS.

Eligibility Criteria

Inclusion Criteria: * Age: 18 to 40 years * Regular ovulatory cycles * Availability of at least one euploid embryo after Trophectoderm biopsy for PGT-A on day 5 or day 6 * Detection of ovulation by P4 rise \> 1.0 ng/ml after LH surge * P4 value of at least 5 ng/ml on day 4 after ovulation Exclusion Criteria: * History of repeated pre-menstrual spotting * Factors affecting the implantation through anatomical changes of the uterus / ovaries or the tubes (adenomyosis, Asherman syndrome, endometriosis, uterine fibroids / polyps, isthmocele with intracavitary fluid presence, hydrosalpinx….)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology